Suguru Ikeda

Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease

Suguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino et al. · Yonago acta medica · 2020 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model

Shintaro Hamada, Tomoaki Takata, Kentaro Yamada et al. · PLoS ONE · 2022 · 20 citations · Full text

Medicine, Biochemistry, Nephrology +17

Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up

Suguru Ikeda, Takaaki Sugihara, Takuya Kihara et al. · Diagnostics · 2021 · 18 citations · Full text

Medicine, Pharmacotherapy, Clinical Nutrition +16